CD47 and neoplasm: Knocking out QPCTL suppressed tumor growth via disrupting monocyte homeostasis, and knocking out QPCTL together with blocking immune checkpoint CD47 has been verified to improve the killing of T-acute lymphoblastic leukemia cells (29, 36).